CVR number 32330304
Industry 46.7600 Wholesale of other intermediate products

CLEVER CEUTICALS ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...
Bankruptcy Risk 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  9.5% 11.2% 14.6% 15.5% 13.6%  
Credit score (0-100)  27 23 14 11 16  
Credit rating  BB BB BB BB BB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
Net sales  89 44 0 0 0  
Gross profit  57.6 17.9 -1.4 -0.4 -0.4  
EBITDA  57.6 17.9 -1.4 -0.4 -0.4  
EBIT  57.6 17.9 -1.4 -0.4 -0.4  
Pre-tax profit (PTP)  56.1 16.0 11.6 14.0 18.5  
Net earnings  56.1 16.0 11.6 14.0 18.5  
Pre-tax profit without non-rec. items  56.1 16.0 11.6 14.0 18.5  
 
See the entire income statement

Balance sheet (kDKK) 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  354 370 381 395 414  
Interest-bearing liabilities  1.5 2.0 0.0 0.5 0.0  
Balance sheet total (assets)  370 372 381 396 414  
Net Debt  -25.8 -17.9 -16.8 -16.1 -15.5  
 
See the entire balance sheet

Volume 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
Net sales  89 44 0 0 0  
Net sales growth  0.0% -50.7% -100.0% 0.0% 0.0%  
Gross profit  57.6 17.9 -1.4 -0.4 -0.4  
Gross profit growth  -56.8% -68.9% 0.0% 68.3% 4.3%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  370 372 381 396 414  
Balance sheet change%  8.7% 0.5% 2.6% 3.8% 4.5%  
Added value  57.6 17.9 -1.4 -0.4 -0.4  
Added value %  64.9% 41.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  
Net sales trend  0.0 -1.0 -2.0 0.0 0.0  
EBIT trend  2.0 3.0 -1.0 -2.0 -3.0  

Profitability 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
EBITDA %  64.9% 41.0% 0.0% 0.0% 0.0%  
EBIT %  64.9% 41.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  100.0% 100.0% 100.0% 100.0% 100.0%  
Net Earnings %  63.2% 36.5% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  63.2% 36.5% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  63.2% 36.5% 0.0% 0.0% 0.0%  
ROA %  16.2% 4.8% 3.3% 3.6% 4.6%  
ROI %  17.3% 4.9% 3.3% 3.6% 4.6%  
ROE %  17.2% 4.4% 3.1% 3.6% 4.6%  

Solidity 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
Equity ratio %  95.7% 99.5% 100.0% 99.9% 100.0%  
Relative indebtedness %  18.0% 4.6% 0.0% 0.0% 0.0%  
Relative net indebtedness %  -12.8% -41.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -44.8% -100.0% 1,200.1% 3,635.0% 3,664.4%  
Gearing %  0.4% 0.5% 0.0% 0.1% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  20.8% 110.8% 101.1% 49.0% 14.6%  

Liquidity 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
Quick Ratio  23.0 184.1 0.0 801.5 0.0  
Current Ratio  23.1 184.1 0.0 801.5 0.0  
Cash and cash equivalent  27.3 19.9 16.8 16.6 15.5  

Capital use efficiency 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  416.6% 849.6% 0.0% 0.0% 0.0%  
Net working capital  353.9 369.8 381.4 395.5 413.9  
Net working capital %  398.6% 845.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0